Pharmaceuticals

Home » All Products » Pharmaceuticals » Reconcile®
Back
  • Reconcile 8 mg/30 ct
  • Reconcile 16 mg/30 ct
  • Reconcile 32 mg/30 ct
  • Reconcile 64 mg/30 ct

Reconcile®

(fluoxetine hydrochloride)

USES

Indicated for the treatment of canine separation anxiety in conjunction with a behavior modification plan.

Federal law restricts this drug to use by or on the order of a licensed veterinarian.

See full prescribing information for complete dosing and administration instructions.

Item #Product NameSupplied
10034057Reconcile® 8 mg Chewable Tablets30 ct. bottle
10036844Reconcile® 8 mg Chewable Tablets90 ct. bottle
10034157Reconcile® 16 mg Chewable Tablets30 ct. bottle
10036944Reconcile® 16 mg Chewable Tablets90 ct. bottle
10034257Reconcile® 32 mg Chewable Tablets30 ct. bottle
10037044Reconcile® 32 mg Chewable Tablets90 ct. bottle
10034357Reconcile® 64 mg Chewable Tablets30 ct. bottle
10037144Reconcile® 64 mg Chewable Tablets90 ct. bottle

PRODUCT INFORMATION

Active Ingredient(s): fluoxetine hydrochloride

IMPORTANT SAFETY INFORMATION:

The most common adverse events reported in decreasing order of reported frequency are: decreased appetite, depression/lethargy, shaking/shivering/tremor, vomiting, restlessness and anxiety, seizures, aggression, diarrhea, mydriasis, vocalization, weight loss, panting, confusion, incoordination, and hypersalivation. Reconcile chewable tablets are contraindicated for dogs with a history of seizures or when used with MAOIs. For product label, including complete safety information, see package insert.

NADA#141-272

WARNINGS:

For oral use in dogs only. Not for human use. Keep out of reach of children.

Show More

OTHER PRODUCTS FROM PRN PHARMACAL